dc.contributor.author |
Lazo Porras, María de los Ángeles |
|
dc.contributor.author |
Bernabé Ortiz, Antonio |
|
dc.contributor.author |
Pinto, Miguel E. |
|
dc.contributor.author |
Ticse Aguirre, Ray Willy |
|
dc.contributor.author |
Málaga Rodríguez, Germán Javier |
|
dc.contributor.author |
Sacksteder, Katherine |
|
dc.contributor.author |
Miranda, J. Jaime |
|
dc.contributor.author |
Gilman, Robert Hugh |
|
dc.date.accessioned |
2020-06-10T18:12:17Z |
|
dc.date.available |
2020-06-10T18:12:17Z |
|
dc.date.issued |
2014 |
|
dc.identifier.uri |
https://hdl.handle.net/20.500.12866/8098 |
|
dc.description.abstract |
AIM: We aimed to estimate the morbidity rate and associated factors for diabetic peripheral neuropathy (DPN) in a low-middle income country setting. METHODS: Cross-sectional study, data was gathered at Peru's Ministry of Health national specialized hospital for endocrinological conditions through standardized interviews, anthropometric measurements and blood tests for glycated haemoglobin (HbA1c). DPN was evaluated using two techniques: the Semmes-Weinstein monofilament test and the diabetic neuropathy symptom score. Overall prevalence and 95% confidence intervals (95% CI) were calculated. Potential factors related to DPN explored included body mass index, years with disease (<10 vs. >/=10 years), glycaemic control (HbA1c <7% vs. >/=7%), microalbuminuria, retinopathy, and current pharmacological treatment. Multivariable analysis was performed using Poisson analysis to calculate prevalence ratios. RESULTS: DPN was observed in 73/129 (56.6%) patients. In multivariable analysis adjusted by age and sex, the prevalence ratio of neuropathy was 1.4 times higher (95% CI 1.07-1.88) in patients who took insulin plus metformin compared to patients who used one treatment alone, and 1.4 higher (95% CI 1.02-1.93) in patients with >/=10 years of disease compared to those with a shorter duration of disease. Also we found some characteristics in foot evaluation associated to neuropathy such as deformities (p<0.001), onychomycosis (p = 0.012), abnormal Achilles reflex (p<0.001), pain perception (p<0.001) and vibration perception (p<0.001). CONCLUSION: DPN is highly frequent among patients with diabetes in a national specialized facility from Peru. Associated factors to DPN included being a diabetic patient for over ten years, and receiving insulin plus metformin. |
en_US |
dc.language.iso |
eng |
|
dc.publisher |
Public Library of Science |
|
dc.relation.ispartofseries |
PLoS ONE |
|
dc.rights |
info:eu-repo/semantics/restrictedAccess |
|
dc.rights.uri |
https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es |
|
dc.subject |
Peru |
en_US |
dc.subject |
Adult |
en_US |
dc.subject |
Female |
en_US |
dc.subject |
Humans |
en_US |
dc.subject |
Male |
en_US |
dc.subject |
Cross-Sectional Studies |
en_US |
dc.subject |
Aged |
en_US |
dc.subject |
Middle Aged |
en_US |
dc.subject |
Prevalence |
en_US |
dc.subject |
Risk Factors |
en_US |
dc.subject |
body mass |
en_US |
dc.subject |
human |
en_US |
dc.subject |
adult |
en_US |
dc.subject |
aged |
en_US |
dc.subject |
cross-sectional study |
en_US |
dc.subject |
female |
en_US |
dc.subject |
male |
en_US |
dc.subject |
middle aged |
en_US |
dc.subject |
middle income country |
en_US |
dc.subject |
socioeconomics |
en_US |
dc.subject |
insulin |
en_US |
dc.subject |
controlled study |
en_US |
dc.subject |
major clinical study |
en_US |
dc.subject |
prevalence |
en_US |
dc.subject |
article |
en_US |
dc.subject |
blood |
en_US |
dc.subject |
morbidity |
en_US |
dc.subject |
microalbuminuria |
en_US |
dc.subject |
glycemic control |
en_US |
dc.subject |
scoring system |
en_US |
dc.subject |
complication |
en_US |
dc.subject |
Hospitals, General |
en_US |
dc.subject |
age distribution |
en_US |
dc.subject |
risk factor |
en_US |
dc.subject |
non insulin dependent diabetes mellitus |
en_US |
dc.subject |
disease duration |
en_US |
dc.subject |
Diabetes Mellitus, Type 2 |
en_US |
dc.subject |
diabetic neuropathy |
en_US |
dc.subject |
hemoglobin A1c |
en_US |
dc.subject |
ambulatory care |
en_US |
dc.subject |
Ambulatory Care |
en_US |
dc.subject |
diabetic patient |
en_US |
dc.subject |
glycosylated hemoglobin |
en_US |
dc.subject |
general hospital |
en_US |
dc.subject |
Hemoglobin A, Glycosylated |
en_US |
dc.subject |
diabetic retinopathy |
en_US |
dc.subject |
diabetic foot |
en_US |
dc.subject |
Diabetic Foot |
en_US |
dc.subject |
outpatient care |
en_US |
dc.subject |
neurologic examination |
en_US |
dc.subject |
nociception |
en_US |
dc.subject |
Diabetic Neuropathies |
en_US |
dc.subject |
achilles reflex |
en_US |
dc.subject |
diabetic neuropathy symptom score |
en_US |
dc.subject |
foot malformation |
en_US |
dc.subject |
onychomycosis |
en_US |
dc.subject |
oral antidiabetic agent |
en_US |
dc.subject |
Semmes Weinstein monofilament test |
en_US |
dc.subject |
vibration |
en_US |
dc.title |
Diabetic peripheral neuropathy in ambulatory patients with type 2 diabetes in a general hospital in a middle income country: a cross-sectional study |
en_US |
dc.type |
info:eu-repo/semantics/article |
|
dc.identifier.doi |
https://doi.org/10.1371/journal.pone.0095403 |
|
dc.subject.ocde |
https://purl.org/pe-repo/ocde/ford#3.02.18 |
|
dc.relation.issn |
1932-6203 |
|